A retrospective case series of 20 patients with immunotherapy-induced bullous pemphigoid with emphasis on management outcomes.

Autor:	Bur D; McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas., Patel AB; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Dermatology, University of Texas Health Science Center at Houston, Houston, Texas., Nelson K; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Huen A; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Pacha O; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Phillips R; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Heberton M; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: MMcIntosh1@mdanderson.org.
Jazyk:	angličtina
Zdroj:	Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2022 Dec; Vol. 87 (6), pp. 1394-1395. Date of Electronic Publication: 2022 Aug 05.
DOI:	10.1016/j.jaad.2022.08.001
Abstrakt:	Competing Interests: Conflicts of interest None disclosed.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect